Cannabis Honey: How It Works and How to Make It

The Lipophilic Paradox

Cannabinoids like THC and CBD are hydrophobic. Because honey is a supersaturated aqueous solution of fructose and glucose, cannabinoids do not dissolve into it. They remain in a colloidal suspension.

Without accounting for this, dosing may be inconsistent. For improved bioavailability, consumption alongside exogenous fats—such as buttered toast, yogurt, or nuts—is recommended. These fats trigger the formation of micelles in the gut, which supports the transport of cannabinoids across the intestinal wall.

Pharmacokinetics: Two Paths to Effect

How one consumes infused honey dictates the metabolic pathway.

Sublingual/Buccal Uptake: When held under the tongue, cannabinoids pass through the mucous membranes. This bypasses the digestive tract, sending Delta-9-THC into the bloodstream. Effects may be felt in 15–30 minutes.

First-Pass Metabolism: Swallowing the honey routes it through the liver. Here, CYP2C9 enzymes oxidize Delta-9-THC into 11-Hydroxy-THC. This metabolite crosses the blood-brain barrier with ease, which may result in more potent effects than inhalation.

The Role of the ECS

The potential utility of honey-infused products relies on the Endocannabinoid System (ECS), the body’s regulatory network for maintaining homeostasis.

CB1 Receptors: Concentrated in the central nervous system. THC binds here to influence excitatory neurotransmitters, which may assist in managing acute pain and sensory regulation.

CB2 Receptors: Found in the immune system and gut. This is where CBD and terpenes like Beta-Caryophyllene interact, supporting the reduction of cytokine production and quieting inflammatory responses.

Terpene-Enzyme Synergy

Honey is biologically active, containing enzymes like glucose oxidase and diastase. These interact with cannabis terpenes in what is termed the Entourage Effect:

Myrcene: Increases cell membrane permeability, which may support the rate at which cannabinoids cross the blood-brain barrier.

Linalool: Often used to support sleep. It interacts with GABA receptors, and when paired with the natural sugars in honey, it may assist in transporting tryptophan to support sedation.

Antioxidant Defense: The phenolic acids in honey work with cannabinoids to neutralize reactive oxygen species (ROS), providing a dual-layered neuroprotective effect.

Why Decarboxylation is Necessary

Raw cannabis contains THCA. Because it has a carboxyl group attached, the molecule is too bulky to bind effectively to CB1 receptors.

Applying heat—roughly 240°F (115°C) for 30–40 minutes—forces the carbon-carbon bond to break and release CO2. Only then does the compound become bio-active THC.

Practical Application

Usage methods influence the outcome:

For Systemic Inflammation: Stirring a teaspoon into warm ginger tea may be effective. Gingerols act as a circulatory stimulant, helping move cannabinoids toward peripheral CB2 receptors.
For Acute Pain/Neuro-Modulation: Use the sublingual method. Holding the honey under the tongue for at least 60–90 seconds supports Delta-9-THC uptake before the liver begins its conversion process.
Managing Glycemic Response: High doses of THC can occasionally trigger a drop in blood sugar. Honey provides a glycemic response that may mitigate the dizziness sometimes associated with high-potency edibles.

Dosage Strategy

11-Hydroxy-THC has a delayed arrival and may take up to 90 minutes to peak.

CB1 receptors have a finite saturation point. Pushing past this does not necessarily offer increased relief and may trigger receptor internalization, where the brain reduces receptor availability to prevent overstimulation. This often leads to the "greening out" experience. Wait at least 90 minutes between doses to give the liver and the ECS time to process the initial intake.

Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

Huestis MA. (2007). Human cannabinoid pharmacokinetics. Chem Biodivers. 4(8):1770-1804. PubMed
Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed
Pertwee RG. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 153(2):199-215. PubMed
Mechoulam R, Parker LA. (2013). The endocannabinoid system and the brain. Annu Rev Psychol. 64:21-47. PubMed
Zgair A, Wong JC, Lee JB, et al. (2016). Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. Am J Transl Res. 8(8):3448-3459. PubMed